Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Technology Sector · ProShares

BIPSX Holdings: What Biotechnology Ultrasector Profund Owns

Ticker BIPSX · Since 2000-06-19 · · Holdings as of Jul 31, 2026

Expense ratio
2.52%$252/yr per $10k
5-yr return
+5.0%annualized
1-yr return
−6.2%as of Dec 2024
Net assets
$118.7Mall share classes
Holdings
159

Bottom line

What does BIPSX hold?

BIPSX held 159 positions as of Jul 31, 2026. Its largest holding is N/a at 6.70% of the fund, and the top 10 positions add up to 30.5%. By asset type it is 78% stocks, 24% repurchase agreements, 2% cash & short-term funds.

Updated Sep 23, 2026

BIPSX top 25 holdings

#HoldingType% of fundValue
1 N/a
SOCIETE' GENERALE 3.53 , 8/03/2026
Repurchase agreements 6.70%$7.9M
2 N/a
CF Secured 3.53 , 8/03/2026
Repurchase agreements 5.15%$6.1M
3 N/a
HSBC SECURITIES (USA), INC. 3.52 , 8/03/2026
Repurchase agreements 4.12%$4.9M
4 N/a
NATWEST MARKETS PLC 3.51 , 8/03/2026
Repurchase agreements 4.12%$4.9M
5 N/a
UMB FINANCIAL CORP. 3.39 , 8/03/2026
Repurchase agreements 3.16%$3.7M
6 Agpxx
Invesco Government & Agency Portfolio
Cash & short-term funds 2.40%$2.9M
7 Apogee Therapeutics Inc
Apogee Therapeutics, Inc.
Stocks 1.29%$1.5M
8 N/a
ROYAL BANK OF CANADA 3.44 , 8/03/2026
Repurchase agreements 1.24%$1.5M
9 Oruka Therapeutics Inc
Oruka Therapeutics, Inc.
Stocks 1.20%$1.4M
10 Dianthus Therapeutics Inc
Dianthus Therapeutics, Inc.
Stocks 1.12%$1.3M
11 Erasca Inc
Erasca, Inc.
Stocks 1.08%$1.3M
12 Twist Bioscience Corp
Twist Bioscience Corporation
Stocks 1.08%$1.3M
13 Kymera Therapeutics Inc
Kymera Therapeutics, Inc.
Stocks 1.05%$1.3M
14 Spyre Therapeutics Inc
Spyre Therapeutics, Inc.
Stocks 1.04%$1.2M
15 Revolution Medicines Inc
Revolution Medicines, Inc.
Stocks 1.04%$1.2M
16 Cg Oncology Inc
CG oncology, Inc.
Stocks 1.03%$1.2M
17 Protagonist Therapeutics Inc
Protagonist Therapeutics, Inc.
Stocks 1.03%$1.2M
18 Praxis Precision Medicines Inc
Praxis Precision Medicines, Inc.
Stocks 1.02%$1.2M
19 Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals, Inc.
Stocks 1.01%$1.2M
20 Cogent Biosciences Inc
Cogent Biosciences, Inc.
Stocks 0.99%$1.2M
21 Natera Inc
Natera, Inc.
Stocks 0.99%$1.2M
22 Arrowhead Pharmaceuticals Inc
Arrowhead Pharmaceuticals, Inc.
Stocks 0.95%$1.1M
23 Travere Therapeutics Inc
Travere Therapeutics, Inc.
Stocks 0.95%$1.1M
24 Roivant Sciences Ltd
Roivant Sciences Ltd.
Stocks 0.95%$1.1M
25 Relay Therapeutics Inc
Relay Therapeutics, Inc.
Stocks 0.95%$1.1M

Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 23, 2026

Asset mix

Stocks78.4%
Repurchase agreements24.5%
Cash & short-term funds2.4%

Country exposure

BM1.0%
CA0.1%
CH0.8%
IE1.0%
KY0.2%
NL0.8%
US98.3%
VG0.4%